頁籤選單縮合
題名 | 臺灣COVID-19疫苗取得與運用之政策評析=Assessment of Covid-19 Vaccine Procurement and Supply in Taiwan |
---|---|
作者 | 許瑜真; 周玉民; 石雅莉; 林宜平; 張雅姿; 楊靖慧; Hsu, Yu-chen; Chou, Yu-min ; Shih, Yi-li; Lin, I-ping ; Chan, Ya-tzu ; Yang, Chin-hui; |
期刊 | 疫情報導 |
出版日期 | 20220823 |
卷期 | 38:16 2022.08.23[民111.08.23] |
頁次 | 頁196-207 |
分類號 | 412.42 |
語文 | chi |
關鍵詞 | COVID-19疫苗; 疫苗採購; 疫苗接種; 涵蓋率; COVID-19 vaccine ; Procurement; Supply; Immunization; Coverage rate; |
中文摘要 | 疫苗接種向來是預防傳染性疾病最具效益的介入措施,自是全球因應COVID-19大流行至為迫切且必要之防治利器。為建立國人對COVID-19的群體免疫力,在COVID-19疫苗尚處於臨床試驗階段,相關安全性、有效性、量產時程及疫苗可獲方案等具體資訊皆不完整的時候,政府即開始進行採購作業的規劃,並採取「國內自製」、「逕洽廠商」及「國際投資(參與COVAX)」等多元管道,期分散風險,購買當下可最快取得的疫苗劑量。 不同於多數國家,我國是在疫情爆發之前就開始推動COVID-19疫苗接種,並自2021年3月22日啟動接種計畫,截至2022年7月26日共收到6,058萬劑疫苗,提供5,929萬人次接種基礎劑、基礎追加劑及追加劑使用,完整接種2劑人口涵蓋率超過85%、追加劑涵蓋率突破71%,已達到WHO全球COVID-19疫苗接種策略於2022年中70%人口完整接種疫苗的目標。 |
英文摘要 | Vaccination is the most effective way to prevent infectious diseases. Since the beginning of the COVID-19 pandemic, vaccination has been deemed to be essential in this fight against the disease. In order to provide COVID-19 vaccines to people in Taiwan, the government began its efforts to procure vaccines as soon as the candidate vaccines entered clinical trials even though information such as safety and efficacy were not available. Multiple channels were pursued by the government to gain access to vaccines, including domestic manufacturing, procurement from international manufactures and participation in the COVAX facility. Unlike most countries, Taiwan started its national COVID-19 vaccination campaign on March 22, 2021, before domestic community outbreaks occurred in May 2021. As of July 26, 2022, around 60.58 million doses of COVID-19 vaccines arrived and were administered to 59.29 million people. The coverage rates for the completed series and a booster dose exceeded 85% and 71%, respectively, higher than the 2022 vaccination target (70%) set in the WHO Global COVID-19 Vaccination Strategy. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。